Literature DB >> 8816407

Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen.

M Rheinnecker1, C Hardt, L L Ilag, P Kufer, R Gruber, A Hoess, A Lupas, C Rottenberger, A Plückthun, P Pack.   

Abstract

We report in this work a human-derived self-assembling polypeptide based on the tetramerization domain of the human transcription factor p53, which can be fused to single-chain Fv Ab (scFv) fragments via a long and flexible hinge sequence of human origin, allowing exploitation of the functional affinity increase of binding to a ligand or cell surface with multimeric binding sites. We have demonstrated the use of this polypeptide by applying it to the construction of a tetrameric scFv against the tumor-associated carbohydrate Ag Lewis Y (Fuc alpha 1-->2Gal beta 1-->4[Fuc alpha 1-->3] GlcNAc beta 1-->3R). For comparison purposes, the corresponding scFv and dimeric mini-antibody, comprising the scFv fused via a flexible murine hinge to an artificial dimerization domain, were also created. The recombinant mini-antibody proteins were expressed in functional form in Escherichia coli and showed the expected m.w. of a dimer and tetramer, respectively. Analysis of Lewis Y-binding behavior by surface plasmon resonance revealed specific but very weak binding of the scFv fragment. In contrast, both dimeric and tetrameric scFv fusion proteins exhibited an enormous gain in functional affinity that was greatest in the case of the tetrameric mini-antibody.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Antibody vectors for imaging.

Authors:  Tove Olafsen; Anna M Wu
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

2.  LSPR Biosensor Signal Enhancement Using Nanoparticle-Antibody Conjugates.

Authors:  W Paige Hall; Salome N Ngatia; Richard P Van Duyne
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2011-02-10       Impact factor: 4.126

3.  Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.

Authors:  Mengyuan Liu; Xiangbin Wang; Changcheng Yin; Zhong Zhang; Qing Lin; Yongsu Zhen; Hualiang Huang
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

4.  Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.

Authors:  David Kiewlich; Jianhuan Zhang; Cynthia Gross; Wei Xia; Brent Larsen; Ronald R Cobb; Sandra Biroc; Jian-Ming Gu; Takashi Sato; David R Light; Tara Heitner; Joerg Willuda; David Vogel; Felipe Monteclaro; Andrzej Citkowicz; Steve R Roffler; Deborah A Zajchowski
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

5.  G-quadruplexes are specifically recognized and distinguished by selected designed ankyrin repeat proteins.

Authors:  Oliver Scholz; Simon Hansen; Andreas Plückthun
Journal:  Nucleic Acids Res       Date:  2014-07-22       Impact factor: 16.971

6.  DeltaPhage--a novel helper phage for high-valence pIX phagemid display.

Authors:  Nicolay R Nilssen; Terje Frigstad; Sylvie Pollmann; Norbert Roos; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  Nucleic Acids Res       Date:  2012-04-26       Impact factor: 16.971

7.  Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Authors:  Roman Fischer; Jessica Marsal; Cristiano Guttà; Stephan A Eisler; Nathalie Peters; John R Bethea; Klaus Pfizenmaier; Roland E Kontermann
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

8.  Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

Authors:  Stefan Harth; Andre Ten Haaf; Christian Loew; Christian Frisch; Achim Knappik
Journal:  MAbs       Date:  2018-12-05       Impact factor: 5.857

9.  Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats.

Authors:  Ami Miller; Stephen Carr; Terry Rabbitts; Hanif Ali
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.